Home › Funds › EMERALD MUTUAL FUND ADVISERS TRUST › CORT
EMERALD MUTUAL FUND ADVISERS TRUST position in CORT
CORCEPT THERAPEUTICS INC · Health Care
EMERALD MUTUAL FUND ADVISERS TRUST reported holding 473,881 shares of CORT (CORCEPT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$54.6M, representing 2.23% of its reported portfolio and ranking #3 among its reported holdings. EMERALD MUTUAL FUND ADVISERS TRUST has disclosed CORT holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How EMERALD MUTUAL FUND ADVISERS TRUST's CORT position evolved
EMERALD MUTUAL FUND ADVISERS TRUST first disclosed a stake in CORT in Q1 2025 at 37,818 shares (US$4.3M). The position peaked in Q3 2026 at 473,881 shares, worth US$54.6M. Across 7 filings, EMERALD MUTUAL FUND ADVISERS TRUST increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 473,881 shares valued at US$54.6M — an increase of 8,979 shares quarter over quarter.. Notable position changes include a 299% increase in Q2 2025 (shares rose 13% over the following quarter), a 159% increase in Q2 2026 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 37.82K | $4.32M | New |
| Q2 2025 | 150.91K | $11.08M | Add |
| Q3 2025 | 158.14K | $13.14M | Add |
| Q4 2025 | 194.35K | $6.76M | Add |
| Q1 2026 | 179.61K | $7.24M | Reduce |
| Q2 2026 | 464.90K | $40.42M | Add |
| Q3 2026 | 473.88K | $54.61M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CORT and 13F data
CORT (CORCEPT THERAPEUTICS INC) is a Health Care company. 37 other funds we track also report a position in CORT — the largest reported positions include Renaissance Technologies (US$558.9M), Parallel Advisors, LLC (US$449.7M), TANG CAPITAL MANAGEMENT LLC (US$130.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CORT
- Renaissance Technologies 4.85M sh · $558.88M · Q3 2026
- Parallel Advisors, LLC 3.90M sh · $449.69M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $130.43M · Q2 2026
- EMERALD ADVISERS, LLC 758.26K sh · $87.37M · Q3 2026
- MPM BioImpact LLC 771.03K sh · $67.04M · Q2 2026
- PERCEPTIVE ADVISORS LLC 398.38K sh · $34.64M · Q2 2026
More on EMERALD MUTUAL FUND ADVISERS TRUST
FAQ
How long has EMERALD MUTUAL FUND ADVISERS TRUST held CORT?
EMERALD MUTUAL FUND ADVISERS TRUST has disclosed CORT holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is EMERALD MUTUAL FUND ADVISERS TRUST's current position in CORT?
As of Q3 2026, EMERALD MUTUAL FUND ADVISERS TRUST holds 473.88K shares of CORT (CORCEPT THERAPEUTICS INC), valued at $54.61M, representing 2.23% of its reported portfolio and ranking #3.
Has EMERALD MUTUAL FUND ADVISERS TRUST been buying or selling CORT?
In the latest 13F filing (Q3 2026), EMERALD MUTUAL FUND ADVISERS TRUST increased its position in CORT. The position peaked in Q3 2026 at 473.88K shares.
Which other funds hold CORT?
Other major institutional holders of CORT include Renaissance Technologies, Parallel Advisors, LLC, TANG CAPITAL MANAGEMENT LLC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.